One of the ways we distinguish ourselves from our competition is by adopting cutting-edge technology. Our high success rates with IVF stem from our process of routine day 5 Preimplantation Genetic Screening (PGS), a Freeze-all vitrification protocol, and Single Embryo Transfer (SET). Being small, we are nimble and can move quickly when new technologies emerge.
FertilitySuccessRates.com by TD Media Inc. shows a comparison of Washington fertility clinics.
That is why we are pleased to announce we will now utilize the MitoScore as part of our IVF process. Our Single Embryo Transfer (SET) policy puts a heavy importance on choosing the right euploid embryo to implant. Using a MitoScore helps Overlake Reproductive Health select those with higher implantation potential increasing the pregnancy rates of our patients.
How It Works
Mitochondria are structures within cells that play an essential role in energy production. They have their own DNA, known as mitochondrial DNA or mtDNA. Studies have shown that an increase in mtDNA content in an embryo indicates a low level of energy and implantation potential. So in IVF, when we have multiple embryos to choose from, we choose the one with the lowest mtDNA for the greatest pregnancy potential. The MitoScore uses the same sample used for PGS so it seamlessly adds another leg-up in helping our embryologists select the best embryo for implantation.
“Reproductive technology is constantly evolving and we are happy to bring these advancements to our patients with partners like Igenomix,” says Dr. Kevin M. Johnson, the Medical Director at ORH. Dr. Johnson has been helping people become parents for over 20+ years and admits he’s excited about the level of precision a MitoScore brings to euploid embryo selection.
